Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer

BACKGROUND: No previous study has addressed the efficacy of NF-κB blockade when bladder tumors develop acquired resistance toward CDDP-treatments. We investigated the changes in NF-κB activation and therapeutic impact of NF-κB blockade by the novel NF-κB inhibitor dehydroxymethyl derivative of epoxy...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Yujiro, Kikuchi, Eiji, Tanaka, Nobuyuki, Kosaka, Takeo, Suzuki, Eriko, Mizuno, Ryuichi, Shinojima, Toshiaki, Miyajima, Akira, Umezawa, Kazuo, Oya, Mototsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424446/
https://www.ncbi.nlm.nih.gov/pubmed/25926105
http://dx.doi.org/10.1186/s12885-015-1315-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424446/
https://www.ncbi.nlm.nih.gov/pubmed/25926105
http://dx.doi.org/10.1186/s12885-015-1315-9

Ejemplares similares